A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients

Full Title

A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100) (NRG-GI011) (CIRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Marsha Reyngold’s office at 631-623-4267.

Protocol

26-073

Phase

Phase III (phase 3)

Investigator

Marsha Reyngold

Co-Investigators

Christopher Crane
Michael May
Matthew McMillan

Diseases

Hepatobiliary › Pancreatic Cancer
Upper Gastrointestinal › Pancreatic Cancer

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT06958328

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description